{"id":"W2794690006","doi":"10.1002/pbc.27023","title":"Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial","year":2018,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation; Children's Neuroblastoma Cancer Foundation","keywords":"Medicine; Neuroblastoma; Vorinostat; Isotretinoin; Refractory (planetary science); Oncology; Clinical trial; Internal medicine; Cancer research; Dermatology; Genetics; Histone; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009836452,0.0007546512,0.001461339,0.0002432287,0.0002602663,0.0005704241,0.0005410814,0.0007186264,0.001503229],"category_scores_gemma":[0.0003933877,0.0002733714,0.0006416261,0.0001965564,0.0005538295,0.0004554114,0.000276804,0.001622899,0.0003657061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006422915,"about_ca_system_score_gemma":0.001029469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007639742,"about_ca_topic_score_gemma":0.002747043,"domain_scores_codex":[0.9997994,0.0001015685,0.00001091393,0.00003354982,0.00002416134,0.000030339],"domain_scores_gemma":[0.9996914,0.00004827225,0.00006201833,0.0000231681,0.00001921581,0.00015606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.506843,0.05068395,0.02166829,0.001543215,0.002059963,0.001953923,0.0009909521,0.007485237,0.1796811,0.0008584854,0.007143965,0.2190879],"study_design_scores_gemma":[0.3767617,0.5808431,0.01902382,0.00005998607,0.0005828186,0.001175465,0.0001213021,0.003378,0.01184278,0.0003174135,0.005853051,0.00004064539],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953903,0.00183103,0.0002339973,0.0002574359,0.00006003912,0.0008299104,0.0003579463,0.00003925917,0.001000053],"genre_scores_gemma":[0.9921041,0.001903717,0.001370754,0.0004143509,0.0001025072,0.001193577,0.0009902375,0.00001675095,0.001903983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001503229,"threshold_uncertainty_score":0.005202055,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0533307255140484,"score_gpt":0.3062926105779968,"score_spread":0.2529618850639484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}